Skip to main content
Premium Trial:

Request an Annual Quote

Protagen, Mikrogen Team on Array-based Dx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protagen today said that it is working with German diagnostics firm Mikrogen on jointly developing infectious disease diagnostics based on Protagen's UNIarray platform.

The firms have conducted a feasibility study for identifying typical autoantibody signatures in infectious diseases that may be useful for diagnostic tests.

"The cooperation with Protagen secures Mikrogen the access to an important and novel technology platform," Erwin Soutschek, co-founder and managing director of Mikrogen, said in a statement. He added that the firms will joinly develop and market marker panels for differential diagnosis of relevant infectious diseases.

Dortmund, Germany-based Protagen has developed the UNIarray platform for developing serum-based diagnostics, as well as the UNIchip line of protein microarrays for development of antibodies.

Financial and other terms of the agreement were not disclosed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.